Sun Pharma's generic Cymbalta gets tentative approval from FDA

11/28/2010 | Business Standard (India)

The FDA has issued tentative marketing approval for Sun Pharmaceutical Industries' duloxetine hydrochloride, a copy of Eli Lilly and Co.'s Cymbalta. The drug is used for treating generalized anxiety disorder, diabetic peripheral neuropathic pain and major depressive disorder. Sun will launch the generic product in 20-, 30- and 60-milligram capsules.

View Full Article in:

Business Standard (India)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX